|
⚲
|
| Keyboard |
| Helix Acquisition Corp
✚
|
|
|---|---|
| CIK # | 0001821586 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001821586] | |
| 10-Q | [0001821586] | |
| 3 | [0001821586] | |
| 4 | [0001821586] | |
| 8-K | [0001821586] | |
| SC 13D | [0001821586] | |
| SC 13G | [0001821586] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MoonLake Immunotherapeutics MLTX
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 520,342 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2026-01-07 | Grant | 354,296 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 520,342 | $0.00 | |
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-12-19 | Conversion | 5,836 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-12-19 | Disposed to issuer | 294,473 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-12-19 | Disposed to issuer | 35,389 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-19 | Conversion | 35,389 | ||
|
MoonLake Immunotherapeutics MLTX
Class C ordinary shares, par value $0.0001 per share
|
2025-12-19 | Disposed to issuer | 196,316 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-19 | Conversion | 196,316 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-19 | Conversion | 294,473 | ||
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-12-19 | Conversion | 8,754 | ||
|
MoonLake Immunotherapeutics MLTX
Common shares, par value CHF 0.10 per share, of MoonLake AG · derivative
|
2025-12-19 | Conversion | 1,052 | ||
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-09 | Sell | 72,908 | $14.43 | 1,052,062 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-09 | Sell | 70,000 | $14.49 | 1,014,300 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-08 | Sell | 130,000 | $15.08 | 1,960,400 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-12-08 | Sell | 130,000 | $15.08 | 1,960,400 |
|
MoonLake Immunotherapeutics MLTX
Class A ordinary shares, par value $0.0001 per share
|
2025-10-08 | Buy | 10,870 | $9.09 | 98,808 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-30 | Sell | 5,827 | $6.96 | 40,556 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 2,800,000 | $6.61 | 18,508,000 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 232,460 | $8.40 | 1,952,664 |
| showing 20 of 153 most recent transactions | |||||